Cancer Trials and Research Unit
What we do
We run clinical trial and clinical research projects on prevention and treatment of cancers (with the exception of blood cancers). Blood cancer research is undertaken by our Haematology Clinical Trials Unit. We run international and national studies led by either pharmaceutical companies or Collaborative Research Groups. These are groups of researchers with overlapping interests who want to work together to develop their research programs.
We are a public service within the Nelune Comprehensive Cancer Centre at the Prince of Wales Hospital.
We are a public service within the Nelune Comprehensive Cancer Centre at Prince of Wales Hospital. We have an experienced team and have been running research trials since 1990.
Our Unit is staffed by a Head of Unit, Program Coordinator, Nurse Unit Manager, Regulatory and Start up Specialists, Administration & Finance Officer, Data Manager, Study Coordinators and Research Nurses.
Our Principal Investigators are medical specialists who are responsible for leading each study. They include:
Medical Oncology Principal Investigators:
- Prof Morteaz Aghmesheh
- Prof Michael Leonard Friedlander
- A/Prof Elizabeth Jane Hovey
- Dr Melvin Chin
- Dr Yeh Chin Lee
- Dr Morteaz Aghmesheh
- Dr Monica Tang
- Dr Ben Kong
Radiation Oncology Principal Investigators:
- Prof Boon Chua
- Prof Michael Jackson
- Dr Stephen Thompson
- Dr Rowena Martin
- Dr Colin Chen
- Dr Wenchang Wong
All Clinical Trials have criteria which need to be met by a patient for them to be involved.
If your Doctor thinks you meet the criteria for a clinical trial, they will need to write you a referral letter. They should send the referral letter to seslhd-pow-ctrureferrals@health.nsw.gov.au
They should attach relevant documents including, your medical history or test results. When we recieve the referral someone from our team will contact you to confirm your details and arrange an appointment.
Please bring:
- Referral from your Specialist Doctor
- Copy of test results confirming your diagnosis
- List of previous cancer related treatments including dates
- Any relevant scans
- List of current medications
Important contact details
Head of Unit:
Dr Amy Prawira
Phone: 02 9382 5131
Fax: 02 9382 5180
Email: Amy.Prawira@health.nsw.gov.au
Nurse Unit Manager:
Ms Kaye Kongrak
Phone: 02 9382 5131
Fax: 02 9382 5180
Email kamonwan.kongrak@health.nsw.gov.au
Site Set Up Specialist
Ms Cherry Singh
Phone: 02 9382 5276
Fax: 02 9382 5180
Email: cherry.singh@health.nsw.gov.au & seslhd-pow-ctruethics@health.nsw.gov.au
Pharmacy
Caley Holgate. Senior Pharmacist – Clinical Trials
Prince of Wales Hospital, Pharmacy Department, High Street, Randwick NSW 2031
Phone 9382 2333
Fax 9382 2345
Email: caley.holgate@health.nsw.gov.au & seslhd-powpharmacytrials@health.nsw.gov.au
Drug delivery
Pharmacy Department
Level 2 via Loading Dock 3, Prince of Wales Hospital, High Street, Randwick NSW 2031
Lab
NSW Health Pathology
Randwick Hospital Laboratory, Randwick Campus, Level 4 Campus Centre, High Street, Randwick NSW 2031 Australia
Radiology
Nuclear Medicine
Level 2, Campus Centre, Prince of Wales Hospital, Barker Street, Randwick NSW 2031 Australia
Wales CT
Medical Imaging Department, Level 0, Campus Centre, Prince of Wales Hospital, Barker Street, Randwick NSW 2031 Australia
Off site archiving
Grace Information Management
9 Hepher Road, Campbelltown NSW 2560 Australia
Phone: 1800 085 434
Email: recordsnsw@grace.com.au
Clinical Trials Research Agreement
Clinical Trial Research Agreement Information
Electronic Medical Records
The Unit utilises an electronic Medical Record (MosaiqTM). This has been assessed to comply with the FDA code 21 CFR part 11.
Clinical Research Associates performing source data verification using Mosaiq will be given personalised username and password to access read only patient data. It is to be noted that the trial unit monitors patient access of CRAs on a regular basis to ensure compliance and patient privacy.
CRA facilities for monitoring visits
We have hot desks available with computers to access our electronic medical records.
All attempts will be made to accommodate monitoring visits within two weeks of first patient on study. Otherwise CRA’s need to book monitoring visits at least 4 weeks in advance.